MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer

被引：0
|
作者：
Aleksandra Kazi
Guy Godwin
John Simpson
Giuseppe Sasso
机构：
[1] Townsville Teaching Hospital,Department of Medical Physics
[2] Auckland Radiation Oncology,Department of Medical Physics
[3] "Centre Medical de Forcilles" PSPH Hospital,Department of Radiation Oncology
[4] James Cook University,Faculty of Medicine, Health and Molecular Sciences
来源：
BMC Cancer | / 10卷
关键词：
Prostate Specific Antigen; Magnetic Resonance Spectroscopy; External Beam Radiation Therapy; High Dose Rate; Dose Volume Histogram;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
    Kazi, Aleksandra
    Godwin, Guy
    Simpson, John
    Sasso, Giuseppe
    BMC CANCER, 2010, 10
  • [2] Dose escalation in dominant intraprostatic lesion with MRI-guided HDR brachytherapy in localized prostate cancer
    Mascarenhas, F.
    Marques, F.
    Germano, S.
    Faustino, S.
    Miguel, C.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S563 - S564
  • [3] HDR Brachytherapy boost irradiation in the radiotherapy (RT) of intermediate and high risk localised prostate cancer
    Agoston, P
    Major, T
    Somogyi, A
    Baricza, K
    Szasz, K
    Lövey, J
    Németh, G
    Kasler, M
    Fodor, J
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S4 - S5
  • [4] Outcomes following HDR Brachytherapy Boost for High Risk Localised Prostate Cancer: Data from a UK Centre
    Lorimer, C.
    Ravi, B.
    Cowtan, F.
    Johns, A.
    Robinson, A.
    Nikapota, A.
    CLINICAL ONCOLOGY, 2023, 35 (02) : E241 - E241
  • [5] Results of prostate cancer patients treated by integrated boost to dominant intraprostatic lesion
    Alitto, A. R.
    Buwenge, M.
    Macchia, G.
    Ntreta, M.
    Siepe, G.
    Galofaro, E.
    Bertini, F.
    Ferioli, M.
    Mazzeo, E.
    Ippolito, E.
    Mantini, G.
    Ferro, M.
    Re, A.
    Cilla, S.
    Valentini, V.
    Deodato, F.
    Morganti, A. G.
    Cammelli, S.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S623 - S624
  • [6] HDR monotherapy brachytherapy for localised prostate cancer
    Hoskin, P. J.
    Bownes, P.
    Bryant, L.
    Ostler, P.
    CLINICAL ONCOLOGY, 2007, 19 (03) : S7 - S7
  • [7] Prostate cancer radiotherapy: a systematic review about boost on the dominant intraprostatic lesion
    Cammelli, S.
    Buwenge, M.
    Giambattista, S.
    Zamagni, A.
    Galofaro, E.
    Valeria, P.
    Ntreta, M.
    Alexopoulou, E.
    Ferro, M.
    Arena, E.
    Macchia, G.
    Deodato, F.
    Cilla, S.
    Djan, I.
    Frezza, G. P.
    Morganti, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S843 - S843
  • [8] MRI-guided Ultrafocal HDR-brachytherapy for Localised Prostate Cancer
    David, John
    Kamrava, Mitchell
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1182 - 1183
  • [9] Dose Differentiated HDR Prostate Brachytherapy a Feasibility Assessment of MRI Guided Dose Escalation to Dominant Intraprostatic Lesions
    Luminais, Christopher
    Cousins, David
    Nourzadeh, Hamidezra
    Aliotta, Eric
    Libby, Bruce
    Showalter, Timothy
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S65 - S65
  • [10] MRI-guided Ultrafocal HDR-brachytherapy for Localised Prostate Cancer Reply
    van Son, Marieke Juliet
    Peters, Max
    Moerland, Marinus A.
    van Zyp, Jochem R. N. van der Voort
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1183 - 1184
12345